Comparative efficacy of switching to natalizumab in active multiple sclerosis

OBJECTIVE: To compare treatment efficacy and persistence in patients who switched to natalizumab versus those who switched between glatiramer acetate (GA) and interferon-beta (IFNβ) after an on-treatment relapse on IFNβ or GA using propensity score matched real-world datasets. METHODS: Patients incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Spelman, Timothy, Kalincik, Tomas, Zhang, Annie, Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Trojano, Maria, Butzkueven, Helmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402083/
https://www.ncbi.nlm.nih.gov/pubmed/25909083
http://dx.doi.org/10.1002/acn3.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402083/
https://www.ncbi.nlm.nih.gov/pubmed/25909083
http://dx.doi.org/10.1002/acn3.180

Ejemplares similares